JPRN-UMIN000018936
Completed
未知
Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetes - Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute Coronary Syndrome (ACS) and diabetes
- Sponsor
- Saitama Medical Center, Jichi Medical University
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •For those who fall into any of the following criteria are excluded from the study: 1\. With a condition of significantly elevated blood glucose, multiple medication or insulin treatment is desirable 2\. The CPK level is over 1000 after ACS onset with suspected cardiomyopathy 3\. With medical history of heart disease 4\. With sever ketoacidosis, diabetic coma, or precoma 5\. Serious infection 6\. Perioperative 7\. Serious physical injury 8\. Showing hypersensitiveness to any compound of teneligliptin 9\. Other conditions where the patient is judged by a physician to be inappropriate to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30
Completed
Not Applicable
A Pilot study of anti-diabetic effects of rich Oligosaccharides fraction which is taken from Rosa arvensis in patients with type 2 diabetesIRCT2013120214333N13Barekat Pharmaceutical Company40
Completed
Not Applicable
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysisdiabetic patients undergoing hemodialysisJPRN-UMIN000010780Diamond study group10
Recruiting
Not Applicable
Efficacy of the medical compound of teneligliptin 20 mg and canagliflozin 100 mg with Free Style Libretype 2 diabetes mellitusJPRN-UMIN000029015TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology40
Completed
Not Applicable
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50